China Oncology Drugs Market 2023 to 2031 Industry Size, Growth Factors, and Market Disruption Analysis

U.S (New York) – Report Ocean has recently published a comprehensive research report titled China Oncology Drugs Market ” Research Report 2023-2031. This report delves deep into the market and offers valuable insights into (Key Market Trends, Emerging Technologies, Market Drivers and Challenges of the Industry, Regulatory Policies), company profiles of key players, and their strategies. With over 100+ market data tables, pie charts, graphs, and figures, this global market study is now available. The report provides a thorough evaluation of the market, (Encompassing Future Trends, Current Growth Factors, Expert Opinions, Factual Information), and industry-validated market data, with a forecast extending until 2031.

The China oncology drugs market was valued at $6,498.2 million in 2018 and is projected to reach $12,688.7 million by 2026, registering a CAGR of 8.7% from 2019 to 2026. Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer according to the data published by WHO. Being the most populous country in the world, cancer rates are significantly rising in China. As per Global Cancer Observatory in 2018, the number of new cancer cases registered each year in China are 4,285,033.

Download Free Sample of This Strategic Report: https://reportocean.com/industry-verticals/sample-request?report_id=AMR81

According to data from the U.S. Bureau of Economic Analysis and the U.S. Census Bureau, the goods and services deficit increased by $1.9 billion from $68.7 billion in January 2023 to $70.5 billion in February. The increase in the goods and services deficit in February was due to a $2.7 billion increase in the goods deficit to $93.0 billion and a $0.8 billion increase in the services surplus to $22.4 billion. Compared to the same period in 2022, the goods and services deficit has dropped this year by $35.5 billion, or 20.3%. $49.5 billion or 10.8% more was exported. 2.2% or $14.0 billion more was spent on imports.

Amongst which, lung cancer constitutes 18.1%; colorectum cancer is about 12.2%; stomach cancer is approximately 10.6%; liver cancer constitutes 9.2%; breast cancer comprises of 8.6% and 41.1% other cancers. The population of China accounts for 19.3% of the global population, and the incidence rate of cancer accounts for 22% of global cancer incidence, ranking first in the world. Cancer deaths in China account for about 27% of global cancer deaths. Cancer mortality in China is also higher than the global average of 17%.

Rise in incidence of various cancer conditions, aging population, westernized diet, shift to sedentary lifestyle, and surge in tobacco smoke exposure due to urbanization in China are the key factors that drive the growth of the cancer. This in turn boosts the growth of the China oncology drugs market. Furthermore, rise in cancer awareness and increase in availability of cancer drugs are expected to boost the market growth. However, the use of traditional Chinese medicine (TCM) to cure cancer and high cost involved in new drug development coupled with threat of failure & adverse effects associated with cancer drugs therapies are expected to restrain the growth of the market. Conversely, high potential of emerging economies and increase in number of pipeline products are expected to provide new opportunities for market players in future.

The China oncology drugs market is segmented based on drug class type and indication. Depending on drug class type, the market is divided into chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. By indication, it is categorized into blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, lung cancer, skin cancer, ovarian cancer, cervical cancer, kidney cancer, and other cancers.

Request To Download Sample of This Strategic Report:- https://reportocean.com/industry-verticals/sample-request?report_id=AMR81

KEY MARKET BENEFITS
> This report entails a detailed quantitative analysis along with the current China oncology drugs market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
> The market forecast is studied from 2019 to 2026.
> The market size and estimations are based on a comprehensive analysis of key developments in the industry.
> A qualitative analysis based on innovative products facilitates strategic business planning.
> The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

LIST of KEY PLAYERS PRofILED IN THE REPORT
> AbbVie Inc.
> Astellas Pharma Inc.
> AstraZeneca PLC
> Bristol-Myers Squibb Company
> Celgene Corporation
> F. Hoffmann-La Roche Ltd.
> Johnson & Johnson
> Shanghai Junshi Biosciences Co., Ltd.
> Beigene
> Jiangsu Hengrui Medicine Co., Ltd

To Get More Business Strategies For Request Sample Report: https://reportocean.com/industry-verticals/sample-request?report_id=AMR81

Key market segments
By Drug Class Type
> Chemotherapy
> Targeted Therapy
> Immunotherapy Therapy
> Hormonal Therapy

By Indication
> Blood Cancer
> Breast Cancer
> Gastrointestinal Cancer
> Prostate Cancer
> Lung Cancer
> Skin Cancer
> Ovarian Cancer
> Cervical Cancer
> Kidney Cancer
> Other Cancers

Why Choose Report Ocean Reports?

Uncovering business opportunities: Our market research reports are invaluable for analyzing potential markets and identifying new product opportunities. They provide insights into customer needs, preferences, and attitudes, as well as facilitate product and service comparisons.

Gaining a clear understanding of your customers: Market reports offer a comprehensive understanding of customers’ needs and desires, empowering your company’s marketing department to enhance products, reduce costs, and improve promotional strategies based on this valuable information.

Data-driven insights: Our market research encompasses a broad spectrum of activities, including market size determination, demand forecasting, competitor analysis, and price monitoring. All these aspects are quantified and measurable, providing you with tangible data-driven insights that enable informed decision-making.

Key Highlights:

Revenue and Sales Estimation: Our reports present historical revenue and sales volume data, which is further triangulated using top-down and bottom-up approaches to forecast the complete market size. Additionally, the report provides estimates for key regions, along with well-recognized types and end-use industries. Macroeconomic factors and regulatory policies are also considered for industry evolution and predictive analysis.

Five Forces Analysis: To enhance market understanding, we conduct a comprehensive five forces analysis that includes evaluating the bargaining power of buyers and suppliers, the threat of new entrants, the threat of substitutes, and the level of rivalry within the market.

Competition: We study leading players in the industry based on their company profile, product portfolio, capacity, product/service pricing, sales performance, and cost/profit analysis.

Demand & Supply and Effectiveness: Our reports provide insights into distribution channels, production, consumption, and, if applicable, import and export activities.

Request full Report:   https://reportocean.com/industry-verticals/sample-request?report_id=AMR81

About US Report Ocean:

We are the best market research reports provider in the industry. Report Ocean is the world’s leading research company, known for its informative research reports. We are committed to providing our clients with both quantitative and qualitative research results. As a part of our global network and comprehensive industry coverage, we offer in-depth knowledge, allowing informed and strategic business conclusions to report. We utilize the most recent technology and analysis tools along with our own unique research models and years of expertise, which assist us to create necessary details and facts that exceed expectations.

Get in Touch with Us:
Report Ocean:

Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES
Tel: +1888 212 3539 (US – TOLL FREE)
Emailsales@reportocean.com
Visit our news websitehttps://reportocean.com

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to Top